Otimar (hydrocortisone 10 mg/ML / neomycin 3.5 mg/ML / polymyxin B 10,000 UNT/ML) Otic Suspension
RxNorm 206525
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 206525 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Otimar (hydrocortisone 10 mg/ML / neomycin 3.5 mg/ML / polymyxin B 10,000 UNT/ML) Otic Suspension.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Hydrocortisone 10 mg/ML / neomycin 3.5 mg/ML / polymyxin B 10000 UNT/ML Otic Suspension [Otimar]
(Atom ID: 12357341)
SY
Synonym (SY):
Otimar (hydrocortisone 1 % / neomycin 0.35 % / polymyxin B 10,000 UNT/ML) Otic Suspension
(Atom ID: 3629465)
SY
Synonym (SY):
Otimar (hydrocortisone 10 mg / neomycin 3.5 mg / polymyxin B 10,000 UNT) per mL Otic Suspension
(Atom ID: 3629464)
PSN